a clinical-stage biopharmaceutical company which develops novel immunotherapy''s
Industry Biotechnology
A.I.dvisor indicates that over the last year, MBIO has been loosely correlated with SLRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if MBIO jumps, then SLRX could also see price increases.
Ticker / NAME | Correlation To MBIO | 1D Price Change % | ||
---|---|---|---|---|
MBIO | 100% | -3.00% | ||
SLRX - MBIO | 57% Loosely correlated | -2.13% | ||
IPHYF - MBIO | 42% Loosely correlated | N/A | ||
SCNI - MBIO | 38% Loosely correlated | -2.61% | ||
MIRM - MBIO | 36% Loosely correlated | +5.33% | ||
MRNS - MBIO | 30% Poorly correlated | +2.12% | ||
More |
Ticker / NAME | Correlation To MBIO | 1D Price Change % |
---|---|---|
MBIO | 100% | -3.00% |
MBIO (2 stocks) | 73% Closely correlated | -3.36% |
pharmaceuticals (159 stocks) | 4% Poorly correlated | -1.90% |
novel medical (11 stocks) | 2% Poorly correlated | -1.33% |